Oranda Therapeutics Limited

Canbridge Pharmaceuticals

This biopharmaceutical company develops and commercialises therapeutic drugs for patients with rare genetic diseases and orphan cancers in China and global markets.

Minoryx

This biotechnology company develops orphan drugs and therapies for patients suffering from rare, life-threatening genetic diseases of the central nervous system.

GondolaBio

This biopharmaceutical company develops clinical-stage and preclinical medicinal therapeutics for patients living with rare genetic diseases.

Genetix Biotherapeutics

The company develops and commercialises gene therapies for patients suffering from severe rare genetic disorders such as sickle cell disease and beta thalassemia.

Actelion Holding Ltd

This biopharmaceutical company develops and commercialises orphan drugs to treat rare diseases, including pulmonary arterial hypertension, for patients worldwide.

Orchard Therapeutics

Orchard Therapeutics develops haematopoietic stem cell gene therapies for patients living with severe genetic diseases.

Minoryx Therapeutic

This biotech company develops therapies for orphan central nervous system diseases, such as X-linked adrenoleukodystrophy, for patients with high unmet medical needs.

Genespire

This company develops off-the-shelf gene therapies for children and adults affected by inherited metabolic diseases and primary immunodeficiencies.